异种肾移植的亚临床研究进展

陈羽翔; 李卓骋; 李涛; 马晓杰; 王毅; 蒋鸿涛

doi:10.3969/j.issn.1674-7445.2023256

异种肾移植的亚临床研究进展

doi: 10.3969/j.issn.1674-7445.2023256

1.
570100　海口，海南医学院第二附属医院移植科
2.
康复科

基金项目: 国家自然科学基金（82260154）；海南省重大科技项目（ZDKJ2019009）；海南省自然科学基金（820RC766、821QN413、821QN409）；海南省临床医学中心建设项目；海南省研究生创新科研课题（Qhys2022-227）；海南医学院研究生创新科研A类课题（HYYB2022A07）

详细信息

作者简介:

通讯作者:
蒋鸿涛（ORCID 0000-0001-9716-3233），Email：jht20032003@163.com

中图分类号: R617, Q78
计量
- 文章访问数: 317
- HTML全文浏览量: 156
- PDF下载量: 64
- 被引次数: 0
出版历程
- 收稿日期: 2023-11-20
- 网络出版日期: 2023-12-12
- 刊出日期: 2024-01-11

Progress in subclinical research of kidney xenotransplantation

1.
Department of Transplantation, the Second Affiliated Hospital of Hainan Medical University, Haikou 570100, China

More Information

Corresponding author: Jiang Hongtao, Email: jht20032003@163.com

摘要

摘要: 异种移植是目前解决临床器官来源短缺的有效途径之一。随着基因编辑技术及免疫抑制方案不断发展，猪-非人灵长类动物异种肾移植相关研究取得了显著进展，为开启异种肾移植临床应用创造了良好条件。鉴于人与非人灵长类动物实质性差异，同时为了满足现阶段的伦理学要求，猪-人异种肾移植的亚临床研究非常必要。近年来，已有关于基因修饰猪-脑死亡受者异种肾移植的亚临床研究，表明异种肾移植已经进入向临床发展的过渡阶段。然而，供受体选择及免疫抑制应用方案尚未统一，亟需在亚临床研究中进一步明确。本文就异种肾移植亚临床研究中供受体选择、免疫抑制方案、移植术后监测管理等方面的现状和当前面临的主要问题进行综述，以期推动异种肾移植向临床转化。
- 异种肾移植 /
- 基因修饰猪 /
- 非人灵长类动物 /
- 免疫抑制药 /
- 排斥反应 /
- 炎症反应 /
- 凝血 /
- 病毒感染
Abstract: Xenotransplantation is an efficient pathway to solve the problem of transplant organ source deficiency in clinical settings. With the increasing progress of gene editing technique and immune suppression regimen, important development has been achieved on researches regarding pig to non-human primate kidney xenotransplantation, which provides a good condition for the introduction of the technique in the clinical application. In view of the substantial difference between human and non-human primate, and to meet the needs of current ethic requirements, it is necessary to perform subclinical studies for pig to human kidney xenotransplantation. In recent years, such subclinical studies with regard to the genetically modified pig to brain death recipient kidney xenotransplantation had been performed, indicating that kidney xenotransplantation gradually began to transit to the clinical development stage. However, donor/recipient selection and immune suppression regimen has not reached a consensus yet, and has to be clarified in subclinical studies. In this article, the current status and confronted problems of donor/recipient selection, immune suppression regimen and post transplantation management in the subclinical studies of kidney xenotransplantation were reviewed, aiming to promote the clinical transformation of kidney xenotransplantation to the clinical application.
- Kidney xenotransplantation /
- Genetically modified pig /
- Non-human primate /
- Immunosuppressant /
- Rejection /
- Inflammation /
- Coagulation /
- Virus infection

HTML全文

下载: 全尺寸图片幻灯片

参考文献(52)

[1]	ZHOU Q, LI T, WANG K, et al. Current status of xenotransplantation research and the strategies for preventing xenograft rejection[J]. Front Immunol, 2022, 13: 928173. DOI: 10.3389/fimmu.2022.928173.
[2]	徐小松. ABO血型不相容肾移植治疗终末期肾病的关键临床问题探讨[J]. 重庆医学, 2023, 52(18): 2721-2725,2740. DOI: 10.3969/j.issn.1671-8348.2023.18.001. XU XS. The key clinical issues of ABO blood group system incompatible kidney transplantation in the treatment of end stage renal disease[J]. Chongqing Med, 2023, 52(18): 2721-2725,2740. DOI: 10.3969/j.issn.1671-8348.2023.18.001.
[3]	ANAND RP, LAYER JV, HEJA D, et al. Design and testing of a humanized porcine donor for xenotransplantation[J]. Nature, 2023, 622(7982): 393-401. DOI: 10.1038/s41586-023-06594-4.
[4]	MONTGOMERY RA, STERN JM, LONZE BE, et al. Results of two cases of pig-to-human kidney xenotransplantation[J]. N Engl J Med, 2022, 386(20): 1889-1898. DOI: 10.1056/NEJMoa2120238.
[5]	PORRETT PM, ORANDI BJ, KUMAR V, et al. First clinical-grade porcine kidney xenotransplant using a human decedent model[J]. Am J Transplant, 2022, 22(4): 1037-1053. DOI: 10.1111/ajt.16930.
[6]	高菲, 王煜, 杜嘉祥, 等. 遗传修饰猪模型在生物医学及农业领域研究进展及应用[J]. 遗传, 2023, 45(1): 6-28. DOI: 10.16288/j.yczz.22-313. GAO F, WANG Y, DU JX, et al. Advances and applications of genetically modified pig models in biomedical and agricultural field[J]. Hereditas, 2023, 45(1): 6-28. DOI: 10.16288/j.yczz.22-313.
[7]	周小青, 刘玉, 唐成程, 等. 敲除GGTA1同时表达人白细胞抗原G5的基因修饰猪的构建[J]. 生物工程学报, 2022, 38(3): 1096-1111. DOI: 10.13345/j.cjb.210655. ZHOU XQ, LIU Y, TANG CC, et al. Generation of genetically modified pigs devoid of GGTA1 and expressing the human leukocyte antigen-G5[J]. Chin J Biotechnol, 2022, 38(3): 1096-1111. DOI: 10.13345/j.cjb.210655.
[8]	TECTOR AJ, MOSSER M, TECTOR M, et al. The possible role of anti-Neu5Gc as an obstacle in xenotransplantation[J]. Front Immunol, 2020, 11: 622. DOI: 10.3389/fimmu.2020.00622.
[9]	COOPER DKC, HARA H, IWASE H, et al. Justification of specific genetic modifications in pigs for clinical organ xenotransplantation[J]. Xenotransplantation, 2019, 26(4): e12516. DOI: 10.1111/xen.12516.
[10]	NAGANO F, MIZUNO T, MIZUMOTO S, et al. Chondroitin sulfate protects vascular endothelial cells from toxicities of extracellular histones[J]. Eur J Pharmacol, 2018, 826: 48-55. DOI: 10.1016/j.ejphar.2018.02.043.
[11]	ZHANG G, HARA H, YAMAMOTO T, et al. Serum amyloid a as an indicator of impending xenograft failure: experimental studies[J]. Int J Surg, 2018, 60: 283-290. DOI: 10.1016/j.ijsu.2018.11.027.
[12]	WATANABE H, ARIYOSHI Y, POMPOSELLI T, et al. Intra-bone bone marrow transplantation from hCD47 transgenic pigs to baboons prolongs chimerism to >60 days and promotes increased porcine lung transplant survival[J]. Xenotransplantation, 2020, 27(1): e12552. DOI: 10.1111/xen.12552.
[13]	CIMENO A, KURAVI K, SORRELLS L, et al. hEPCR. hTBM. hCD47. hHO-1 with donor clodronate and DDAVP treatment improves perfusion and function of GalTKO. hCD46 porcine livers perfused with human blood[J]. Xenotransplantation, 2022, 29(2): e12731. DOI: 10.1111/xen.12731.
[14]	HINRICHS A, RIEDEL EO, KLYMIUK N, et al. Growth hormone receptor knockout to reduce the size of donor pigs for preclinical xenotransplantation studies[J]. Xenotransplantation, 2021, 28(2): e12664. DOI: 10.1111/xen.12664.
[15]	MOHIUDDIN MM. Pig-to-primate organ transplants require genetic modifications of donor[J]. Nature, 2023, 622(7982): 244-245. DOI: 10.1038/d41586-023-02817-w.
[16]	KOZLOV M. Monkey survives for two years after gene-edited pig-kidney transplant[J]. Nature, 2023, 622(7983): 437-438. DOI: 10.1038/d41586-023-03176-2.
[17]	SIEMS C, HUDDLESTON S, JOHN R. A brief history of xenotransplantation[J]. Ann Thorac Surg, 2022, 113(3): 706-710. DOI: 10.1016/j.athoracsur.2022.01.005.
[18]	GANCHIKU Y, RIELLA LV. Pig-to-human kidney transplantation using brain-dead donors as recipients: one giant leap, or only one small step for transplantkind?[J]. Xenotransplantation, 2022, 29(3): e12748. DOI: 10.1111/xen.12748.
[19]	中华医学会器官移植学分会异种移植学组. 异种移植临床研究指导意见(2018建议版)[J]. 器官移植, 2018, 9(6): 405-408. DOI: 10.3969/j.issn.1674-7445.2018.06.001. Xenotransplantation Group of Organ Transplantation Credit Association of Chinese Medical Association. Guidelines for clinical research of xenotransplantation (2018 recommended version) [J]. Organ Transplant, 2018, 9(6): 405408. DOI: 10.3969/j.issn.1674-7445.2018.06.001.
[20]	YU XH, DENG WY, JIANG HT, et al. Kidney xenotransplantation: recent progress in preclinical research[J]. Clin Chim Acta, 2021, 514: 15-23. DOI: 10.1016/j.cca.2020.11.028.
[21]	LADOWSKI JM, HARA H, COOPER DKC. The role of SLAs in xenotransplantation[J]. Transplantation, 2021, 105(2): 300-307. DOI: 10.1097/TP.0000000000003303.
[22]	HARA H, NGUYEN H, WANG ZY, et al. Evidence that sensitization to triple-knockout pig cells will not be detrimental to subsequent allotransplantation[J]. Xenotransplantation, 2021, 28(4): e12701. DOI: 10.1111/xen.12701.
[23]	MOHIUDDIN MM, SINGH AK, CORCORAN PC, et al. Chimeric 2C10R4 anti-CD40 antibody therapy is critical for long-term survival of GTKO. hCD46. hTBM pig-to-primate cardiac xenograft[J]. Nat Commun, 2016, 7: 11138. DOI: 10.1038/ncomms11138.
[24]	ADAMS AB, KIM SC, MARTENS GR, et al. Xenoantigen deletion and chemical immunosuppression can prolong renal xenograft survival[J]. Ann Surg, 2018, 268(4): 564-573. DOI: 10.1097/SLA.000000000000 2977.
[25]	ANWAR IJ, DELAURA I, LADOWSKI J, et al. Complement-targeted therapies in kidney transplantation-insights from preclinical studies[J]. Front Immunol, 2022, 13: 984090. DOI: 10.3389/fimmu.2022.984090.
[26]	VIGLIETTI D, GOSSET C, LOUPY A, et al. C1 inhibitor in acute antibody-mediated rejection nonresponsive to conventional therapy in kidney transplant recipients: a pilot study[J]. Am J Transplant, 2016, 16(5): 1596-1603. DOI: 10.1111/ajt.13663.
[27]	RÖTH A, BARCELLINI W, D'SA S, et al. Sutimlimab in cold agglutinin disease[J]. N Engl J Med, 2021, 384(14): 1323-1334. DOI: 10.1056/NEJMoa2027760.
[28]	ESKANDARY F, JILMA B, MÜHLBACHER J, et al. Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial[J]. Am J Transplant, 2018, 18(4): 916-926. DOI: 10.1111/ajt.14528.
[29]	ADAMS AB, LOVASIK BP, FABER DA, et al. Anti-C5 antibody tesidolumab reduces early antibody-mediated rejection and prolongs survival in renal xenotransplantation[J]. Ann Surg, 2021, 274(3): 473-480. DOI: 10.1097/SLA.0000000000004996.
[30]	GAO Y, SHAN W, GU T, et al. Daratumumab prevents experimental xenogeneic graft-versus-host disease by skewing proportions of T cell functional subsets and inhibiting T cell activation and migration[J]. Front Immunol, 2021, 12: 785774. DOI: 10.3389/fimmu.2021.785774.
[31]	BOCKERMANN R, JÄRNUM S, RUNSTRÖM A, et al. Imlifidase-generated single-cleaved IgG: implications for transplantation[J]. Transplantation, 2022, 106(7): 1485-1496. DOI: 10.1097/TP.0000000000004031.
[32]	DELAURA I, ZIKOS J, ANWAR IJ, et al. The impact of IdeS (imlifidase) on allo-specific, xeno-reactive, and protective antibodies in a sensitized rhesus macaque model[J]. Xenotransplantation, 2023, DOI: 10.1111/xen.12833[Epub ahead of print
[33]	HANSEN-ESTRUCH C, COOPER DKC, JUDD E. Physiological aspects of pig kidney xenotransplantation and implications for management following transplant[J]. Xenotransplantation, 2022, 29(3): e12743. DOI: 10.1111/xen.12743.
[34]	HANSEN-ESTRUCH C, BIKHET MH, JAVED M, et al. Renin-angiotensin-aldosterone system function in the pig-to-baboon kidney xenotransplantation model[J]. Am J Transplant, 2023, 23(3): 353-365. DOI: 10.1016/j.ajt.2022.11.022.
[35]	FIRL DJ, MARKMANN JF. Measuring success in pig to non-human-primate renal xenotransplantation: systematic review and comparative outcomes analysis of 1051 life-sustaining NHP renal allo- and xeno-transplants[J]. Am J Transplant, 2022, 22(6): 1527-1536. DOI: 10.1111/ajt.16994.
[36]	KIM SC, MATHEWS DV, BREEDEN CP, et al. Long-term survival of pig-to-rhesus macaque renal xenografts is dependent on CD4 T cell depletion[J]. Am J Transplant, 2019, 19(8): 2174-2185. DOI: 10.1111/ajt.15329.
[37]	IWASE H, HARA H, EZZELARAB M, et al. Immunological and physiological observations in baboons with life-supporting genetically engineered pig kidney grafts[J]. Xenotransplantation, 2017, 24(2):e12293. DOI: 10.1111/xen.12293.
[38]	LI T, JIANG H, LIU H, et al. Extracellular histones and xenotransplantation[J]. Xenotransplantation, 2020, 27(5): e12618. DOI: 10.1111/xen.12618.
[39]	LU T, YANG B, WANG R, et al. Xenotransplantation: current status in preclinical research[J]. Front Immunol, 2020, 10: 3060. DOI: 10.3389/fimmu.2019.03060.
[40]	宋佳华, 余一凡, 邓文艺, 等. 异种肾移植: 生理学研究的现状及发展趋势[J]. 器官移植, 2023, 14(6): 898-904. DOI: 10.3969/j.issn.1674-7445.2023148. SONG JH, YU YF, DENG WY, et al. Kidney xenotransplantation: the present situation and development trend of physiological research[J]. Organ Transplant, 2023, 14(6): 898-904. DOI: 10.3969/j.issn.1674-7445.2023148.
[41]	BOSE S, VOLPATTI LR, THIONO D, et al. A retrievable implant for the long-term encapsulation and survival of therapeutic xenogeneic cells[J]. Nat Biomed Eng, 2020, 4(8): 814-826. DOI: 10.1038/s41551-020-0538-5.
[42]	蒋鸿涛, 李涛, 何松哲, 等. 基因修饰猪-非人灵长类动物异种肾移植面临的问题及挑战[J]. 器官移植, 2022, 13(6): 810-817. DOI: 10.3969/j.issn.1674-7445.2022.06.018. JIANG HT, LI T, HE SZ, et al. Problems and challenges of genetically modified pig-non-human primate xenotransplantation[J]. Organ Transplant, 2022, 13(6): 810-817. DOI: 10.3969/j.issn.1674-7445.2022.06.018.
[43]	DENNER J. Porcine endogenous retroviruses and xenotransplantation, 2021[J]. Viruses, 2021, 13(11): 2156. DOI: 10.3390/v13112156.
[44]	曾嘉庆, 高岩, 仇相书, 等. 猪逆转录病毒SYBR Green Ⅰ荧光定量PCR检测方法的建立及应用[J]. 中国病原生物学杂志, 2022, 17(1): 26-30. DOI: 10.13350/j.cjpb.220107. ZENG JQ, GAO Y, QIU XS, et al. Establishment and application of fluorescence quantitative PCR for detection of porcine retrovirus SYBR Green Ⅰ[J]. Chin J Pathog Biolo, 2022, 17(1): 26-30. DOI: 10.13350/j.cjpb.220107.
[45]	PISANO MP, GRANDI N, TRAMONTANO E. High-throughput sequencing is a crucial tool to investigate the contribution of human endogenous retroviruses (HERVs) to human biology and development[J]. Viruses, 2020, 12(6): 633. DOI: 10.3390/v12060633.
[46]	GU W, ZENG N, ZHOU L, et al. Genomic organization and molecular characterization of porcine cytomegalovirus[J]. Virology, 2014, 460/461: 165-172. DOI: 10.1016/j.virol.2014.05.014.
[47]	GRIFFITH BP, GOERLICH CE, SINGH AK, et al. Genetically modified porcine-to-human cardiac xenotransplantation[J]. N Engl J Med, 2022, 387(1): 35-44. DOI: 10.1056/NEJMoa2201422.
[48]	DENNER J, LÄNGIN M, REICHART B, et al. Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival[J]. Sci Rep, 2020, 10(1): 17531. DOI: 10.1038/s41598-020-73150-9.
[49]	HALECKER S, HANSEN S, KRABBEN L, et al. How, where and when to screen for porcine cytomegalovirus (PCMV) in donor pigs for xenotransplantation[J]. Sci Rep, 2022, 12(1): 21545. DOI: 10.1038/s41598-022-25624-1.
[50]	SINGH AK, GRIFFITH BP, GOERLICH CE, et al. The road to the first FDA-approved genetically engineered pig heart transplantation into human[J]. Xenotransplantation, 2022, 29(5): e12776. DOI: 10.1111/xen.12776.
[51]	GARDINER D, MCGEE A, SIMPSON C, et al. Baseline ethical principles and a framework for evaluation of policies: recommendations from an international consensus forum[J]. Transplant Direct, 2023, 9(5): e1471. DOI: 10.1097/TXD.0000000000001471.
[52]	徐莹, 陈佳弘, 何松哲, 等. 移植相关人群对异种肾移植的态度及影响因素[J]. 器官移植, 2023, 14(5): 683-690. DOI: 10.3969/j.issn.1674-7445.2023118. XU Y, CHEN JH, HE SZ, et al. Attitude and influencing factors of transplant-related population towards kidney xenotransplantation[J]. Organ Transplant, 2023, 14(5): 683-690. DOI: 10.3969/j.issn.1674-7445.2023118.